Inflammatory signaling pathways regulating Tumor necrosis factor-alpha, Interleukin-6, and Interleukin-1 beta expression

The inflammatory signaling pathways regulating the expression of Tumor necrosis factor-alpha (TNF-α), Interleukin-6 (IL-6), and Interleukin-1 beta (IL-1β) comprise a complex network of intracellular cascades essential for the innate immune response (Liu et al., 2017, Signal Transduct Target Ther). Central to these pathways are the Nuclear Factor-kappa B (NF-κB) system, Mitogen-Activated Protein Kinase (MAPK) cascades, and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathway (O'Shea & Plenge, 2012, Nature Reviews Drug Discovery). These pathways are typically activated by Pattern Recognition Receptors (PRRs), such as Toll-like receptors (TLRs), which detect pathogens or endogenous danger signals (Zhang & An, 2007, Int Anesthesiol Clin). Upon activation, these cascades trigger the transcription and secretion of pro-inflammatory cytokines that coordinate local and systemic inflammation. Dysregulation of these signaling networks is a primary driver of chronic inflammatory and autoimmune diseases, including rheumatoid arthritis, Crohn's disease, and systemic lupus erythematosus (Dinarello, 2011, Blood). Consequently, these pathways are major targets for therapeutic intervention. Drugs such as Adalimumab (anti-TNF), Tocilizumab (anti-IL-6R), and Anakinra (IL-1 receptor antagonist) work by neutralizing the cytokines or blocking their receptors, while small molecules like Tofacitinib inhibit upstream JAK kinases. While effective, these therapies carry significant safety concerns, primarily related to systemic immunosuppression and an increased risk of serious infections.

Other names

Pro-inflammatory cytokine signaling networkNF-kappaB/MAPK/JAK-STAT axisCytokine signaling pathwaysInnate immune signaling

Inhibition of pro-inflammatory cytokine signaling through direct neutralization of ligands, blockade of cell-surface receptors, or pharmacological inhibition of intracellular signal-transducing kinases.